Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194245 | SCV000248593 | pathogenic | Muscular dystrophy | 2015-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765233 | SCV004568151 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2; Autosomal recessive limb-girdle muscular dystrophy type 2N | 2023-09-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp226Cysfs*6) in the POMT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMT2 are known to be pathogenic (PMID: 15894594). This variant is present in population databases (rs755660222, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with POMT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 211951). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004567396 | SCV005052434 | likely pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 | 2024-01-16 | criteria provided, single submitter | clinical testing |